I

Intra-Cellular Therapies

D
ITCI
USD
1.16
(1.2981%)
Market Closed
14,971.00
Volume
-0.87
EPS
-
Div Yield
-105.255810
P/E
9,564,970,051.00
Market Cap
Today
1.4230%
1 Week
6.833%
1 Month
27.153%
6 Months
27.099%
12 Months
60.953%
Year To Date
26.442%
All Time
0%

Title:
Intra/Cellular Therapies

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that addressneeds in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
Do you need help or have a question?